[go: up one dir, main page]

CU23313A1 - Mã0/00todo de obtenciã"n de estructuras cocleares. composiciones vacunales y adyuvantes basados en estructuras cocleares y sus intermediarios - Google Patents

Mã0/00todo de obtenciã"n de estructuras cocleares. composiciones vacunales y adyuvantes basados en estructuras cocleares y sus intermediarios

Info

Publication number
CU23313A1
CU23313A1 CU20020292A CU20020292A CU23313A1 CU 23313 A1 CU23313 A1 CU 23313A1 CU 20020292 A CU20020292 A CU 20020292A CU 20020292 A CU20020292 A CU 20020292A CU 23313 A1 CU23313 A1 CU 23313A1
Authority
CU
Cuba
Prior art keywords
structures
coclear
obtaining
intermediaries
adjusts based
Prior art date
Application number
CU20020292A
Other languages
English (en)
Inventor
Sua Rez Carlos Taboada
Marta Nez Danay Gil
Vignier Caridad Zayas
Guez Rama Rez Tamara Rodra
Gonza Lez Nestor Mora
Morales Rama N Faustin Barbera
Gonza Lez Victoriano Gu Sierra
Campo Alonso Judith Ma Nic Del
Grandos Gustavo Rafael Bracho
Gonza Lez Miriam De San Lastre
Rez Marta N Oliver Germa N Pa
Huergo Concepcia N Campa
Original Assignee
Inst Finlay Ct De Investigacia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Finlay Ct De Investigacia filed Critical Inst Finlay Ct De Investigacia
Priority to CU20020292A priority Critical patent/CU23313A1/es
Priority to PCT/CU2003/000016 priority patent/WO2004047805A1/es
Priority to ES03773445T priority patent/ES2376227T3/es
Priority to AT03773445T priority patent/ATE530166T1/de
Priority to CN2003801092585A priority patent/CN1744883B/zh
Priority to HK06109275.1A priority patent/HK1088827B/xx
Priority to CA002518906A priority patent/CA2518906A1/en
Priority to ARP030104387A priority patent/AR042237A1/es
Priority to US10/536,778 priority patent/US20060134134A1/en
Priority to AU2003281911A priority patent/AU2003281911A1/en
Priority to EP03773445A priority patent/EP1602360B1/en
Priority to DK03773445.6T priority patent/DK1602360T3/da
Priority to EP10185705A priority patent/EP2347764A3/en
Priority to BR0316687-2A priority patent/BR0316687A/pt
Priority to ZA200504729A priority patent/ZA200504729B/en
Publication of CU23313A1 publication Critical patent/CU23313A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/008—Leishmania antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se relaciona con el campo de la Inmunología, específicamente con la rama de los adyuvantes y las vacunas. El objetivo técnico que se persigue es obtener estructuras cocleares a partir de vesículas de membrana externa (ampollas) de microorganismos, con el fin de emplearlas como adyuvantes o como vacunas en sí. La invención también se relaciona con el método de obtención de las estructuras cocleares. </P>
CU20020292A 2002-11-27 2002-11-27 Mã0/00todo de obtenciã"n de estructuras cocleares. composiciones vacunales y adyuvantes basados en estructuras cocleares y sus intermediarios CU23313A1 (es)

Priority Applications (15)

Application Number Priority Date Filing Date Title
CU20020292A CU23313A1 (es) 2002-11-27 2002-11-27 Mã0/00todo de obtenciã"n de estructuras cocleares. composiciones vacunales y adyuvantes basados en estructuras cocleares y sus intermediarios
PCT/CU2003/000016 WO2004047805A1 (es) 2002-11-27 2003-11-27 Obtencion de estructuras cocleares, composiciones vacunales, adyuvantes y sus intermediarios.
ES03773445T ES2376227T3 (es) 2002-11-27 2003-11-27 Procedimiento de obtención de estructuras cocleares, composiciones de vacuna, adyuvantes y sus intermedios.
AT03773445T ATE530166T1 (de) 2002-11-27 2003-11-27 Verfahren zum erhalt von kochleär-strukturen, impfzusammensetzungen, hilfsmittel und zwischenprodukte davon
CN2003801092585A CN1744883B (zh) 2002-11-27 2003-11-27 获得蜗形结构的方法、其疫苗组合物、佐剂以及中间体
HK06109275.1A HK1088827B (en) 2002-11-27 2003-11-27 Method of obtaining cochlear structures, vaccine compositions, adjuvants and intermediates thereof
CA002518906A CA2518906A1 (en) 2002-11-27 2003-11-27 Method of obtaining cochlear structures, vaccine compositions, adjuvants and intermediates thereof
ARP030104387A AR042237A1 (es) 2002-11-27 2003-11-27 Obtencion de estructuras cocleares, composiciones vacunales, adyuvantes y sus intermediarios
US10/536,778 US20060134134A1 (en) 2002-11-27 2003-11-27 Method of obatining cochlear structures, vaccine compositions, adjuvants and interme- diates thereof
AU2003281911A AU2003281911A1 (en) 2002-11-27 2003-11-27 Method of obtaining cochlear structures, vaccine compositions, adjuvants and intermediates thereof
EP03773445A EP1602360B1 (en) 2002-11-27 2003-11-27 Method of obtaining cochlear structures, vaccine compositions, adjuvants and intermediates thereof
DK03773445.6T DK1602360T3 (da) 2002-11-27 2003-11-27 Fremgangsmåde til opnåelse af sneglestrukturer, vaccinesammensætninger, adjuvanser og mellemprodukter dertil
EP10185705A EP2347764A3 (en) 2002-11-27 2003-11-27 Method of obtaining cochlear structures, vaccine compositions, adjuvants and intermediates thereof
BR0316687-2A BR0316687A (pt) 2002-11-27 2003-11-27 Composição e adjuvante vacinal e método para a obtenção de estruturas cocleares a partir de vesìculas de membrana externa de organismos vivos
ZA200504729A ZA200504729B (en) 2002-11-27 2005-06-09 Method of obtaining cochlear structures, vaccine compositions, adjuvants and intermediates thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20020292A CU23313A1 (es) 2002-11-27 2002-11-27 Mã0/00todo de obtenciã"n de estructuras cocleares. composiciones vacunales y adyuvantes basados en estructuras cocleares y sus intermediarios

Publications (1)

Publication Number Publication Date
CU23313A1 true CU23313A1 (es) 2008-09-25

Family

ID=40122451

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20020292A CU23313A1 (es) 2002-11-27 2002-11-27 Mã0/00todo de obtenciã"n de estructuras cocleares. composiciones vacunales y adyuvantes basados en estructuras cocleares y sus intermediarios

Country Status (13)

Country Link
US (1) US20060134134A1 (es)
EP (2) EP2347764A3 (es)
CN (1) CN1744883B (es)
AR (1) AR042237A1 (es)
AT (1) ATE530166T1 (es)
AU (1) AU2003281911A1 (es)
BR (1) BR0316687A (es)
CA (1) CA2518906A1 (es)
CU (1) CU23313A1 (es)
DK (1) DK1602360T3 (es)
ES (1) ES2376227T3 (es)
WO (1) WO2004047805A1 (es)
ZA (1) ZA200504729B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009049013A2 (en) * 2007-10-09 2009-04-16 Tufts University Cholera vaccines
CU20080215A7 (es) 2008-11-19 2012-06-21 Inst Finlay Vacunas unitemporales
WO2011027956A2 (ko) 2009-09-04 2011-03-10 주식회사이언메딕스 그람 양성 박테리아에서 유래한 세포밖 소포체 및 이를 이용한 질병 모델
CU20100083A7 (es) 2010-05-05 2012-06-21 Inst Finlay Tolerogenos adyuvados como vacuna de malaria
CU20110202A7 (es) 2011-11-02 2013-12-27 Inst Finlay Ct De Investigación Producción De Sueros Y Vacunas Composición inmunogénica de polisacáridos planos adyuvados y las formulaciones resultantes
EP2689775A1 (en) 2012-07-25 2014-01-29 Instituto Finlay, Centro de Investigacion-Produccion de vacunas y sueros Cochleate with only one mamp
WO2021031270A1 (zh) * 2019-08-22 2021-02-25 四川大学 细菌膜囊泡及其分离制备系统和方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US597572A (en) * 1898-01-18 Indicator for oil-wells
CH588887A5 (es) 1974-07-19 1977-06-15 Battelle Memorial Institute
GB1578776A (en) 1976-06-10 1980-11-12 Univ Illinois Hemoglobin liposome and method of making the same
GB2026340B (en) 1978-07-03 1982-12-22 Ash P Stabilising microvesicles
DE2848965A1 (de) 1978-11-11 1980-05-22 Behringwerke Ag Verfahren zur herstellung von membranproteinen aus neisseria meningitidis und diese enthaltende vaccine
US4271147A (en) 1980-01-10 1981-06-02 Behringwerke Aktiengesellschaft Process for the isolation of membrane proteins from Neisseria meningitidis and vaccines containing same
US4663161A (en) 1985-04-22 1987-05-05 Mannino Raphael J Liposome methods and compositions
JPH01125328A (ja) 1987-07-30 1989-05-17 Centro Natl De Biopreparados 髄膜炎菌ワクチン
WO1993014744A1 (en) * 1992-02-04 1993-08-05 Chiron Corporation Non-toxic lipid vaccine formulations
US5643574A (en) * 1993-10-04 1997-07-01 Albany Medical College Protein- or peptide-cochleate vaccines and methods of immunizing using the same
US5994318A (en) * 1993-10-04 1999-11-30 Albany Medical College Cochleate delivery vehicles
US5851536A (en) 1995-11-22 1998-12-22 University Of Washington Therapeutic delivery using compounds self-assembled into high axial ratio microstructures
US5834015A (en) * 1996-09-11 1998-11-10 Albany Medical College Protein-lipid vesicles and autogenous vaccine comprising the same
US6180114B1 (en) 1996-11-21 2001-01-30 University Of Washington Therapeutic delivery using compounds self-assembled into high axial ratio microstructures
GB9918319D0 (en) 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
NO20002828D0 (no) * 2000-06-02 2000-06-02 Statens Inst For Folkehelse Proteinholdig vaksine mot Neisseria meningtidis serogruppe samt fremgangsmÕte ved fremstilling derav
GB0103170D0 (en) * 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition

Also Published As

Publication number Publication date
EP2347764A3 (en) 2011-10-26
EP2347764A2 (en) 2011-07-27
BR0316687A (pt) 2005-10-18
AU2003281911A1 (en) 2004-06-18
DK1602360T3 (da) 2012-02-13
CA2518906A1 (en) 2004-06-10
HK1088827A1 (en) 2006-11-17
ATE530166T1 (de) 2011-11-15
WO2004047805A1 (es) 2004-06-10
EP1602360A1 (en) 2005-12-07
US20060134134A1 (en) 2006-06-22
ZA200504729B (en) 2006-09-27
CN1744883B (zh) 2011-06-08
AR042237A1 (es) 2005-06-15
EP1602360B1 (en) 2011-10-26
ES2376227T3 (es) 2012-03-12
CN1744883A (zh) 2006-03-08

Similar Documents

Publication Publication Date Title
GT200200133A (es) Formulaciones de latex libres de aceleradores, metodos para hacer dichas formulaciones y articulos hechos de los mismos
SV2004001690A (es) Nuevos derivados de fluoroglicosidos heterociclicos, medicamentos que contienen estos compuestos, y el uso de los mismos
CY1109471T1 (el) Μεθοδοι και μεσα για την παραγωγη υαλουρονανης
UY27729A1 (es) Inhibidores de quinasas.
BRPI0413867A (pt) dispositivo e método para implantação de célula intradérmica
ES2108125T3 (es) Aporte in vivo de factores activos por implantes de celulas cultivadas conjuntamente.
ECSP034924A (es) Derivados sustituidos del 1-oxa-2,8-daza-espiro[4,5]dec-2-eno
TR200002259T2 (tr) Esnetilerek kristalize edilebilir elastomerlerden tıbbi implantlar ve implantasyon metotları.
CU23313A1 (es) Mã0/00todo de obtenciã&#34;n de estructuras cocleares. composiciones vacunales y adyuvantes basados en estructuras cocleares y sus intermediarios
DE60329211D1 (de) Cytarabin-monophosphate prodrugs
CL2021001276A1 (es) Dispositivos y sistemas de difusión microfluídica y métodos de fabricación y uso de estos (divisional de la solicitud n° 201902831)
DK1563061T3 (da) Dyrkning af hårinducerende celler
MXPA04001277A (es) Imidazopiridinas triciclicas.
AR061810A1 (es) Derivados de sulfamato de benzotiofeno, medicamentos que los contienen, usos para prevenir o tratar enfermedades dependientes de estrogenos y metodo de preparacion
ECSP056201A (es) Triazolopirimidinas
MX2020001853A (es) Métodos para mejorar la viabilidad de los órganos.
ECSP056247A (es) Triazolopirimidinas
AR006084A1 (es) Aminofeniluracilos substituidos y empleo de los mismos para la lucha contra las plantas indeseables
AR029617A1 (es) Procedimiento para preparar secretagogos de hormonas del crecimiento y polimorfo de los compuestos obtenidos
DE50205952D1 (de) Kosmetische Mikroemulsionen enthaltend Ectoin oder Derivate
BR112013017715A2 (pt) membrana de separação de gás e método de fabricação e uso
ES2073180T3 (es) Vacuna adecuada para combatir la bacteria bordetella pertussis.
AR003977A1 (es) Composiciones endoparasiticidas a base de didepsipeptidos, nuevos didepsipeptidos y procedimientos para su produccion.
EA200501258A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
ATE377412T1 (de) Sonnenschutzmittel mit einem silika-gemisch